Endometrial adenocarcinomas have two main signatures, SOX9+LGR5+ and SOX9+LGR5−, indicating that these distinct transcriptomic signatures reflect differences in pathogenesis and disease progression. The gene discussed is SOX9; the disease is endometrium adenocarcinoma.